Logo image of MLTX

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:MLTX - KY61559X1045 - Common Stock

15.91 USD
+0.05 (+0.32%)
Last: 1/26/2026, 8:03:59 PM
15.93 USD
+0.02 (+0.13%)
Pre-Market: 1/27/2026, 8:12:40 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MLTX revenue by date.MLTX revenue by date.
N/AN/AN/AN/A
323.85%		N/A
162.08%		N/A
63.79%		N/A
42.36%		N/A
23.36%		N/A
4.12%
EBITDA
YoY % growth
MLTX ebitda by date.MLTX ebitda by date.
N/AN/A-53.58M-65.05M
-21.41%		-54.11M
16.82%		-141.706M
-161.89%		N/A
-73.85%		N/A
-15.11%		N/A
29.04%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MLTX ebit by date.MLTX ebit by date.
-105.76K-53.58M
-50,561.88%		-65.06M
-21.43%		-54.123M
16.81%		-143.091M
-164.38%		N/A
-76.62%		N/A
-10.93%		N/A
-6.98%		N/A
42.80%		N/A
120.13%		N/A
663.80%		N/A
15.35%		N/A
48.84%		N/A
-16.65%
Operating Margin
MLTX operating margin by date.MLTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MLTX eps by date.MLTX eps by date.
N/AN/AN/AN/A-0.76
49.48%		-1.89
-148.68%		N/A
-92.85%		N/A
-0.99%		N/A
6.69%		N/A
15.54%		N/A
56.54%		N/A
194.26%		N/A
180.69%		N/A
64.02%		N/A
-29.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.01
-40.00%		-0.93
-47.24%		-0.94
-8.35%		-0.95
13.19%		-0.96
4.68%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-73.192M
-51.86%		-71.806M
-52.43%		-71.889M
-20.66%		-73.062M
-5.02%		N/A
EBIT
Q2Q % growth		-72.052M
-45.32%		-71.571M
-50.72%		-72.049M
-18.70%		-73.051M
-2.26%		-70.346M
2.37%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -1.10
-96.43%		-0.90-0.20-22.75%
Q2 2025
Q2Q % growth		 -0.87
-123.08%		-0.74-0.13-18.26%
Q1 2025
Q2Q % growth		 -0.63
-186.36%		-0.770.1417.89%
Q4 2024
Q2Q % growth		 -0.72
-500.00%		-0.61-0.11-18.11%
Q3 2024
Q2Q % growth		 -0.56
-211.11%		-0.44-0.12-26.10%
Q2 2024
Q2Q % growth		 -0.39
-69.57%		-0.28-0.11-37.92%
Q1 2024
Q2Q % growth		 -0.22
4.35%		-0.20-0.02-11.55%
Q4 2023
Q2Q % growth		 -0.12
61.29%		-0.230.1148.88%
Q3 2023
Q2Q % growth		 -0.18
33.33%		-0.230.0522.46%
Q2 2023
Q2Q % growth		 -0.23
32.35%		-0.270.0415.13%
Q1 2023
Q2Q % growth		 -0.23 -0.320.0927.32%
Q4 2022
Q2Q % growth		 -0.31 -0.330.027.18%
Q3 2022
Q2Q % growth		 -0.27 -0.330.0617.45%
Q2 2022
Q2Q % growth		 -0.34 -0.550.2138.27%
MLTX Yearly EPS VS EstimatesMLTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MLTX Yearly Revenue VS EstimatesMLTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.1% -10.7% -0.33% -8.63%
RevenueN/A N/A N/A N/A